CClinicalTrials.gg
CompletedNCT02350803Updated Jan 30, 2015

Does Use of Rigid Fixation After Removing Distraction Osteogenesis Device Reduce the Relapse?

A Phase 2 interventional study of mini plate in Cleft Palate, Maxillary Hypoplasia and Maxillary Retrognathism, sponsored by Shiraz University of Medical Sciences. Completed at 1 site in Iran, Islamic Republic of. Open to participants aged 18 Years to 28 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-30.

Sponsored by Shiraz University of Medical Sciences · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 28 Years
Sex
All
01

Study summary

patients were enrolled by the inclusion criteria and were undergo lefort 1 maxillary osteotomy. after the latency phase the distraction was done in anterior- posterior vector. patients were divided by randomized allocation in 2 groups. in group 1 the distractor was removed after consolation phase, and in group 2 fixation devices were placed immediately after removal of distractors. data regarding relapse were analyzed by lateral cephalogram X-ray taken in 3 different phases of the trial. change of occlusal plane and the "A point" of the cephalometric analysis were determined as reference point of the study.

Read the detailed description

All patients were undergo maxillary Lefort 1 osteotomy with intra oral distractors bilaterally. The latency phase was considered 5 days for all of them. Distraction was done in the anterior- posterior vector with 1 mm/day rate. In group 1 distraction devices were removed after finishing distraction and a 3 months consolation, in group 2 fixation devices (4 L shaped miniplates with 16 screws) were placed immediately after removing distractors.

The amount of horizontal and vertical relapse were determined in the "A point" 2 years after finishing distraction.

By using lateral cephalogram X-ray as a raw data base, taken in 3 occasions: preoperatively, immediately after finishing consolation phase and removing distractor with placing fixation devices or without them and 2 years postoperatively in every subject. Relevant skeletal points were determined and digitized to evaluate 2-dimensional skeletal changes during and after surgery and to subsequently determine the amount of relapse. The same X-ray machine and settings were used for all cephalograms.Patients were stabilized in the lateral Cephalogram unit (Planmeca, ProMax, Helsinki-Finland) using Cephalostat. With the position of the patients with their head oriented at 90 degree angle to the X-Ray beam at a distance of 5ft from the tube. The jaws were in maximum intercuspation, tip of the tongue behind the upper incisor teeth and lips in relaxed position. The receptor (CR, Konica Minolta medical imaging, USA) was placed 15 inches from the head. This is a standard under which all cephalometric radiographs are taken. It ensures that radiographs, taken in different times, are directly comparable.

Radiographic exposures were 60-80 Kvp, 10-15 mA, and 16-32 sec, and repeated for each case in three occasions.

The radiographs were processed in laser readout processor special for mentioned CR system. PACS. A DICOM system used for saving and transferring the images.

All Lateral cephalograms were traced by hand and digitized, superimposed and evaluated by the same examiner. The tracings were rechecked by another examiner.

02

Conditions studied

  • Cleft Palate
  • Maxillary Hypoplasia
  • Maxillary Retrognathism

Keywords

  • distraction osteogenesis
  • mini plate
  • Lefort 1 osteotomy
03

In context

Cleft Palate

131 studies on the registry are indexed under Cleft Palate; 36 are open to participants now.

This study's enrollment of 20 is below the median of 40 across 85 interventional studies indexed under Cleft Palate.

Browse Cleft Palate studies →

Lead sponsor

Shiraz University of Medical Sciences is the lead sponsor of 129 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 28 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

patients need lefort 1 maxillary advancement more than 8 mm and have presurgical orthodontic preparation

Exclusion criteria

Exclusion Criteria:

patients with cleft lip and alveolar cleft ,traumatic patients ,patients with previous orthognathic surgery in the maxilla and edentulous patients

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (actual)

Study arms

  • Placebo comparator
    distraction osteogenesis

    treatment of maxillary deficiency was done just by distraction osteogenesis and no mini plate was used after removal of distractor

  • Active comparator
    distraction osteogenesis+ mini plate

    treatment of maxillary deficiency was done just by distraction osteogenesis and after removal of distractor 4 mini plate L shaped was used after removal of distractor as an intervention

    Device: mini plate

Interventions

  • Devicemini plate

    in the intervention group, 4 L shaped titanium mini plates with 16 screws were fixed immediately after distraction phase and removal of distraction ossteogenesis to prevent the relapse after distraction

06

What researchers measure

Primary outcomes

  1. "A point" of lateral cephalometry X-ray

    "A point" is used to determine the horizontal and vertical relapse

    Time frame: 2 years after finishing the distraction

Secondary outcomes

  1. occlusal plane

    changes in occlusal plane is determine to assess the amount of relapse

    Time frame: 2 years after distraction is finished

07

Study locations

1 site
  • shiraz University of medical sciences
    Shiraz, Fars, Iran, Islamic Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02350803
Lead sponsor
Shiraz University of Medical Sciences
Responsible party
Reza Tabrizi (Assistant professor of oral and maxillofacial surgery, Shiraz University of Medical Sciences) — Principal investigator
First posted
Jan 30, 2015
Start date
Feb 2011
Primary completion
Mar 2013
Completion
Dec 2014
Last update
Jan 30, 2015

Study contacts

Reza Tabrizi, DMD
study director · Shiraz University of Medical Sciences
Touba Karagah, DMD
principal investigator · Shiraz University of Medical Sciences
Negin Matini, DMD
principal investigator · Shahid Beheshti University of Medical Sciences

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion